Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
STATE NET® THOUGHT LEADERSHIP SERIES How Historic Adoption Rates Hold the Key to Forecasting Future Regulatory Action Just as state legislatures vary in their bill passage rates, some state agencies...
Judge Strikes Down Part of MD Digital Ad Tax Law A federal judge struck down a provision of Maryland’s first-in-the-nation digital advertising tax law that prohibited online companies from notifying...
NLRB Sues California to Block Labor Board Law The National Labor Relations Board has filed a lawsuit to block a new California law ( AB 288 ) empowering the state’s Public Employee Relations Board...
TX AG Sues Johnson & Johnson over Claimed Tylenol-Autism Link Texas Attorney General Ken Paxton (R) filed a lawsuit against Johnson & Johnson this week claiming the company hid the risks of Tylenol...
Over the past 47 years, seven states have enacted their own, state-level versions of the federal Community Reinvestment Act to ensure financial institutions within their jurisdictions are meeting the banking...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
Telemedicine Still ‘Critical Focus’ for State Lawmakers: This year states passed at least 176 bills that adjust existing laws to accommodate the higher demand for telehealth services since the Covid-19 pandemic. That total roughly equals the 171 bills enacted in 2023, indicating that “telehealth remains a critical focus of state legislative efforts, showcasing its growing role in the healthcare landscape,” according to the Center for Connected Health Policy, a national nonprofit that advocates for state and federal telehealth policies. (PLURIBUS NEWS, CENTER FOR CONNECTED HEALTH POLICY)
NY Gov Signs EpiPen Insurance Bill: New York Gov. Kathy Hochul (D) signed a bill (SB 7114) that will require health insurers to cover EpiPens, used to treat severe allergic reactions. The measure also caps consumer out-of-pocket costs for the devices at $100. Some reports indicate the cost of EpiPens has risen 600% since 2007, according to Hochul’s office. (STATE OF POLITICS, LEXISNEXIS STATE NET)
—Compiled by SNCJ Managing Editor KOREY CLARK